AKAntoni Klamka

Antoni Klamka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Antoni Klamka has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Association Between LPR, Obstructive Sleep Apnea, and Asthma - A Narrative Review

    by Matylda BęDkowska-Kuśmierek, Anna Złotnik, Kinga Krzysztofik, Antoni Klamka, Paulina Kawalec, Kamil Bronikowski, Maksymilian Ryszkowski, Krystian Fornal, Natalia BęDkowska-Kuśmierek, Sabina Zaborowska

    Background: Laryngopharyngeal reflux (LPR), obstructive sleep apnea (OSA), and asthma are common disorders increasingly recognized as interconnected conditions sharing inflammatory and mechanical mechanisms. Their coexistence may worsen symptoms and reduce quality of life. Aim: To review current evidence regarding the association between LPR, OSA, and asthma, including shared pathophysiological mechanisms and clinical implications. Material and Methods: A narrative review of meta-analyses, observational studies, and clinical reports examining prevalence, pathophysiology, clinical presentation, and treatment strategies related to LPR, OSA, and asthma. Results: Studies demonstrate a significant overlap among these conditions. LPR is frequently observed in patients with OSA and asthma, while OSA prevalence is increased in asthmatic individuals. Proposed mechanisms include chronic inflammation, obesity, autonomic dysfunction, upper airway instability, and nocturnal hypoxia, creating a bidirectional cycle in which each disorder may aggravate the others. Continuous positive airway pressure (CPAP) therapy may improve reflux symptoms and asthma control, whereas proton pump inhibitor treatment for LPR often provides limited benefit. Conclusions: LPR, OSA, and asthma may represent an overlapping clinical triad rather than isolated diseases. Awareness of their coexistence may improve diagnosis and support multidisciplinary management. Further prospective studies are needed to clarify causal relationships and optimize treatment strategies.

  • Open Access

    Large Language Models in Medicine: Opportunities, Limitations, and Future Directions – A Scoping Review

    by Antoni Klamka, Paulina Kawalec, Kamil Bronikowski, Maksymilian Ryszkowski, Krystian Fornal, Natalia BęDkowska-Kuśmierek, Sabina Zaborowska, Paulina Pawlak, Olaf Wojcieszuk, Łukasz Starczewski

    Introduction. Large language models (LLMs) are increasingly used in healthcare and health-related fields, including clinical decision support, personalized medicine, digital health, and sports performance monitoring. However, concerns regarding reliability, transparency, and safety continue to limit their broader implementation. Materials and Methods. A scoping review of 24 PubMed-indexed studies published between 2023 and 2026 was conducted to assess current applications, benefits, limitations, and future directions of LLMs in healthcare. Results. LLMs are being applied in clinical decision support, diagnostics, biomedical research, personalized healthcare, and digital health solutions. They can enhance information retrieval, clinical reasoning, literature synthesis, health monitoring, and sports-related applications such as training support and performance optimization. Emerging trends include retrieval-augmented generation, multimodal systems, and specialized AI agents. Key challenges include hallucinations, limited explainability, privacy concerns, and insufficient clinical validation. Conclusions. LLMs have significant potential to improve healthcare, biomedical research, and health-oriented sports applications. Currently, they should serve as supportive tools rather than autonomous decision-makers. Further progress requires robust validation, regulatory oversight, and effective human–AI collaboration.

  • Open Access

    REVISITING THE SAFETY PROFILE OF TOPICAL CALCINEURIN INHIBITORS IN ATOPIC DERMATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2015–2026) IN THE CONTEXT OF PUBLIC HEALTH REGULATIONS

    by Anna Złotnik, Kinga Krzysztofik, Antoni Klamka, Paulina Kawalec, Kamil Bronikowski, Maksymilian Ryszkowski, Krystian Fornal, Natalia BęDkowska-Kuśmierek, Sabina Zaborowska, Paulina Pawlak

    Background. Atopic Dermatitis (AD) is a widespread, chronic inflammatory-related skin con-dition. Despite the effectiveness of topical calcineurin inhibitors (TCIs), their use is often limited by "TCI phobia" fueled by FDA "black box" warnings regarding potential oncological risks. These warnings were based on animal model studies conducted early in the development of the drug and systemic transplantation data. Aim. The aim of this study is to evaluate the oncological safety of TCIs in patients with atopic dermatitis by synthesizing the latest epidemiological evidence (2015–2026) and to discuss the implications of current public health regulator restrictions. Material and methods. A systematic review and meta-analysis adhered to the PRISMA 2020 guidelines. Databases (PubMed, Embase) were searched for cohort and case-control studies. Ten high-quality studies (Newcastle-Ottawa Scale ≥7) were selected. Statistical analysis was performed using JASP (Version 0.18.3) with a random-effects model (Restricted ML) to calcu-late pooled Relative Risks (RR) and evaluate heterogeneity (I2). Results. The quantitative synthesis included diverse age and geographical cohorts. The analysis revealed that TCI use is not associated with a statistically significant increase in the overall risk of malignancy (pooled RR = 0.97; 95% CI: 0.82–1.15; p = 0.529). Heterogeneity was non-existent (I2 = 0%). Long-term data (e.g., APPLES study) and large-scale pharmacovigilance reports (17 million FAERS records) confirmed no increased risk of lymphomas or hematopoietic malignancies. Conclusions. The oncological safety profile of TCIs is favorable and supported by pharmaco-kinetic evidence, that shows minor systemic absorption (< 1.0 ng/mL). Systemic cancer cases associated with TCI(s) are most likely historically attributed to protopathic bias. These findings strongly supports the removal of the "black box" warnings to reduce "TCI phobia" and improve therapeutic outcomes and quality of life for AD patients.

  • Open Access

    Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency epidemiology, etiopathogenesis, clinical presentation, treatment – a systematic review

    by Adrianna Babik, Kamila Kamińska, Matylda BęDkowska-Kuśmierek, Anna Złotnik, Kinga Anna Krzysztofik, Antoni Klamka, Paulina Kawalec, Kamil Bronikowski, Maksymilian Ryszkowski, Krystian Fornal

    Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders of the adrenal cortex caused by a deficiency of an enzyme involved in adrenal steroidogenesis. In the majority of cases (95%), this deficiency affects the enzyme 21-hydroxylase. A deficiency or complete absence of enzymes involved in steroidogenesis disrupts the steroidogenic pathways, resulting in increased synthesis of steroid hormone precursors, which leads to an excess of adrenal androgens and virilization in female patients. The aim of this study was to review the current literature on the epidemiology, etiopathogenesis, and clinical presentation of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, as well as to discuss contemporary treatment methods for this condition. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is a complex disorder with a broad clinical spectrum, requiring a multidisciplinary diagnostic and therapeutic approach. The pathophysiology of the disease is based on cortisol and aldosterone deficiency combined with an excess of adrenal androgens, which results in different clinical presentations depending on the patient's age, sex, and the severity of the genetic variant. The implementation of universal newborn screening based on 17OHP measurement has significantly reduced mortality associated with adrenal crisis, particularly in boys, in whom the normal appearance of the external genitalia delayed diagnosis. Replacement therapy with hydrocortisone and fludrocortisone, although effective, does not fully replicate the physiological circadian rhythm of cortisol secretion and is associated with a risk of numerous long-term complications. Therapeutic prospects include CRF receptor antagonists, molecules inhibiting ACTH secretion, and gene therapy, although none of these approaches has yet entered routine clinical practice.

  • Open Access

    Association Between Psoriasis and Hashimoto’s Thyroiditis - A Systematic Review

    by Kinga Anna Krzysztofik, Antoni Klamka, Paulina Kawalec, Kamil Bronikowski, Maksymilian Ryszkowski, Krystian Fornal, Natalia BęDkowska-Kuśmierek, Sabina Zaborowska, Paulina Pawlak, Olaf Wojcieszuk

    Background Psoriasis is a chronic immune-mediated inflammatory disease increasingly associated with other autoimmune disorders, including autoimmune thyroid diseases, particularly Hashimoto’s thyroiditis. In recent years, numerous studies have investigated the relationship between psoriasis and thyroid dysfunction; however, the available evidence remains partly inconsistent. Objective The aim of this study was to evaluate the association between psoriasis and autoimmune thyroid diseases based on available observational studies, systematic reviews, and meta-analyses. Methods A literature review was conducted using publications available in PubMed, PMC, Frontiers, and MDPI databases. Observational studies, systematic reviews, meta-analyses, and Mendelian randomization studies investigating the relationship between psoriasis and thyroid diseases were included. Data regarding the prevalence of AITD, thyroid autoantibodies, and thyroid dysfunction in patients with psoriasis were analyzed. Results Available evidence indicates that patients with psoriasis have an increased risk of autoimmune thyroid diseases. In the meta-analysis by Zhang et al., including 253,313 psoriasis patients and 1,376,533 controls, psoriasis was associated with a significantly increased risk of AITD (OR = 1.76; 95% CI: 1.35–2.28), particularly Hashimoto’s thyroiditis (OR = 1.88; 95% CI: 1.50–2.35). Observational studies also demonstrated higher levels of anti-TPO and anti-TG antibodies, more frequent thyroid dysfunction, and ultrasonographic changes suggestive of thyroid autoimmunity among psoriasis patients. Conclusions Psoriasis is associated with an increased prevalence of autoimmune thyroid diseases, especially Hashimoto’s thyroiditis. The observed relationship may result from shared immunological and genetic mechanisms. Further prospective and causal studies are required to better understand the nature of this association.

  • Open Access

    Physical activity as a non pharmacological intervention in Alzheimer’s disease: a narrative review

    by Sabina Zaborowska, Paulina Pawlak, Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik, Kamila Kamińska, Matylda BęDkowska-Kuśmierek, Anna Złotnik, Kinga Krzysztofik, Antoni Klamka

    Background. Alzheimer’s disease (AD) is the leading cause of dementia, and disease‑modifying pharmacological options remain limited. Physical activity (PA) has emerged as a promising modifiable factor to mitigate cognitive decline and disease progression. Aim. To synthesize evidence from clinical and mechanistic studies on the effects of PA in AD, with emphasis on cognition, disease course, and key biological pathways. Material and methods. A targeted narrative search of PubMed and Scopus identified English‑language studies (2002–2025), prioritizing randomized controlled trials, systematic reviews, and meta‑analyses of exercise or PA interventions in individuals with AD, mild cognitive impairment, or preclinical AD; additional observational and mechanistic work was used to contextualize clinical findings. Evidence was synthesized qualitatively, without formal risk‑of‑bias assessment or quantitative meta‑analysis, focusing on cognition, neuropsychiatric symptoms, function, quality of life, and major mechanistic domains. Results. Most studies show that PA improves global cognition (especially executive function) and reduces neuropsychiatric symptoms, while memory effects are more limited. Resistance and multicomponent training yield greater cognitive benefits than aerobic exercise alone, likely via enhanced neurotrophic signaling, reduced Aβ/tau pathology, improved insulin sensitivity, attenuated neuroinflammation, and increased cerebral blood flow. Moderate‑intensity PA (≈150–180 min/week) appears optimal, slowing clinical progression most clearly in preclinical and mild AD, although effects on quality of life remain inconsistent. Conclusions. PA is a promising, safe, and accessible non‑pharmacological intervention, particularly in earlier AD stages, and should be considered a core component of strategies to reduce the burden of AD.

  • Open Access

    Physical activity and pharmacological interventions in reversing stress-induced hippocampal atrophy: An analysis of molecular mechanisms

    by Paulina Pawlak, Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik, Kamila Kamińska, Matylda BęDkowska-Kuśmierek, Anna Złotnik, Kinga Krzysztofik, Antoni Klamka, Paulina Kawalec

    Background: Chronic stress, unlike its acute adaptive form, leads to a persistent disruption of homeostasis and an increasing allostatic load. A central component of the biological response to stress is the activation of the hypothalamic-pituitary-adrenal (HPA) axis, which leads to the release of glucocorticoids, particularly cortisol. The hippocampus, due to its high density of glucocorticoid receptors, becomes one of the main target structures for cortisol action. Its chronic excess becomes neurotoxic to the hippocampal structure and leads to its atrophy. Aim:The aim of this study is to analyze the mechanisms leading to hippocampal damage and to evaluate the clinical evidence regarding the reversibility of these changes through pharmacological and non-pharmacological interventions. Material and methods:The literature review was conducted by searching the electronic databases PubMed and Google Scholar. The search process utilized a combination of the logical operators AND/OR and the following keywords: chronic stress, cortisol, hippocampal atrophy, neuroplasticity, HPA axis, BDNF, physical exercise. Results: Chronic exposure to cortisol leads to dendritic atrophy, loss of synaptic spines, and inhibition of neurogenesis within the hippocampus. Recent reports, however, highlight the key role of the mTORC1 signaling pathway and BDNF expression in reversing these deficits. While psychoplastogens such as ketamine promote rapid synaptic remodeling, regular physical activity facilitates sustained structural adaptations.Conclusions: Hippocampal damage caused by chronic stress is not a completely irreversible process. The transition from a neurotoxic state to structural regeneration is possible through multi-track molecular pathways activated by both modern pharmacotherapy and systematic physical activity. This synergy opens new perspectives in education and sports medicine, aiming at the biological reconstruction of brain structures and improvement of the quality of life.

  • Open Access

    The Association Between Sugar-Sweetened Beverage (SSB) Consumption and Gut Microbiota Composition and Related Metabolites in Adults: A Systematic Review

    by Kamila Kamińska, Matylda BęDkowska-Kuśmierek, Anna Złotnik, Kinga Krzysztofik, Antoni Klamka, Paulina Kawalec, Kamil Bronikowski, Maksymilian Ryszkowski, Krystian Fornal, Natalia BęDkowska-Kuśmierek

    Background. Sugar-Sweetened Beverages (SSB) are a major source of dietary sugars worldwide. Emerging evidence suggests that dietary factors, including sugar intake, may influence the composition of the gut microbiota, which plays a crucial role in human physiology. However, the relationships between habitual SSB intake, gut microbiota composition, and related metabolites in adults remain insufficiently studied. Aim. This systematic review aimed to synthesize available evidence on the associations between SSB consumption, gut microbiota composition, and related metabolite profiles in adults, while identifying methodological differences and gaps in literature. Material and methods. A systematic search identified observational studies investigating SSB intake and gut microbiota or metabolite outcomes in healthy adult populations. Results. Higher SSB intake was consistently associated with alterations in gut microbial composition, including shifts in the Firmicutes: Bacteroidetes ratio. Changes included reductions in short-chain fatty acid producing species including Eubacterium eligens, Ruminococcus callidus, and several Clostridium species. Metabolomic analyses revealed changes in branched-chain amino acids, aromatic amino acids, glycerophospholipids and bile acids with distinct patterns observed for specific SSB types. Overall, 56 serum metabolites were significantly related to SSB intake and implicated in diabetes risk. SSB was also linked to higher visceral adiposity index, total and LDL-cholesterol. Added sugar intake was positively associated with the genus Lachnobacterium. Conclusions. Habitual SSB consumption may influence gut microbial composition and related metabolites in adults, contributing to metabolic dysregulation. The limited number of studies, methodological differences and observational nature of available evidence, highlight the need for interventional studies and the necessity of standardized methods.

  • Open Access

    BPC-157 and GHK-Cu in Wound Healing and Tissue Repair: A Review of Clinical Efficacy and Safety

    by Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik, Kamila Kamińska, Matylda BęDkowska-Kuśmierek, Anna Złotnik, Kinga Krzysztofik, Antoni Klamka, Paulina Kawalec, Kamil Bronikowski

    Background: BPC-157 and GHK-Cu are synthetic peptides with potential in tissue repair, influencing molecular mechanisms in healing, angiogenesis and inflammation. Objective: This review synthesizes preclinical and clinical research on BPC-157 and GHK-Cu efficacy and safety in wound healing and tissue repair, examining mechanistic pathways and translational potential in clinical and sports medicine. Methods: Literature searches of PubMed, Embase and Cochrane Library included studies on wound healing, tissue regeneration, safety and clinical uses of BPC-157 and GHK-Cu without publication date restrictions. Results: Preclinical studies show BPC-157 promotes skin, tendon, muscle and bone healing via specific signaling pathways and growth factor upregulation. GHK-Cu enhances collagen/elastin synthesis, angiogenesis and fibroblast migration. Limited human trials evaluated BPC-157 for knee pain and IV safety, while GHK-Cu showed promise in skin quality trials. Both appear safe but lack comprehensive RCTs. Conclusion: BPC-157 and GHK-Cu show therapeutic potential in wound healing, though evidence is largely preclinical. Extensive human trials are needed to establish clinical efficacy. This review provides groundwork for future research and highlights safety for sports medicine practitioners.


  • Open Access

    Beyond Exercise: Sport-Based, Family-Centered, and Technology-Assisted Interventions Supporting Children with Autism Spectrum Disorder

    by Piotr Szopa, Antoni Klamka, Sabina Jóźwiak, Simone Szymczyk, Aleksandra Komoń, Kacper Król, Artur Grobelny, Aleksandra Płusa, Olga Stodulska, Urszula Załuska

    BackgroundAutism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition characterized by deficits in social communication and restricted, repetitive behaviors. Its growing prevalence and functional burden have increased interest in non-pharmacological interventions, particularly physical activity and sport-based programs, as potential strategies to improve physical and neurobehavioral outcomes in pediatric populations. AimThis narrative review aimed to summarize current evidence on the effects of physical activity and exercise interventions on motor, cognitive, behavioral, and psychosocial outcomes in children and adolescents with ASD. Material and methodsA narrative literature review was conducted using peer-reviewed studies on exercise-based interventions in pediatric ASD populations. Included were systematic reviews, meta-analyses, randomized controlled trials, and experimental studies assessing outcomes such as motor skills, executive functioning, social interaction, sleep, and behavioral regulation. ResultsEvidence indicates that structured physical activity may positively affect multiple domains in children with ASD. Exercise interventions were associated with improvements in motor skills, executive functions, and social abilities, along with reductions in behavioral problems and anxiety. Some studies also reported improved sleep and overall well-being. However, significant heterogeneity in intervention types, duration, and outcome measures was noted. ConclusionsPhysical activity is a valuable complementary element of multidisciplinary ASD management, supporting both physical health and neurobehavioral functioning. Further well-designed studies with standardized protocols and long-term follow-up are needed to determine optimal intervention strategies and their sustained effects.